BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myeloma-Reference-Cited by-同舟云学术

BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myeloma

Published:2018-11-12 Issue:3 Volume:96 Page:209-214
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Requirand Guilhem¹²,Robert Nicolas¹²,Boireau Stéphanie¹²,Vincent Laure³,Seckinger Anja⁴⁵,Bouhya Salaheddine³,Ceballos Patrice³,Cartron Guillaume³⁶,Hose Dirk⁴⁵,Klein Bernard¹²⁶,Moreaux Jérôme¹²⁶⁷^ORCID

Affiliation:

1. CHU Montpellier, Department of Biological Hematology Montpellier France

2. IGH, CNRS, University of Montpellier Montpellier France

3. CHU Montpellier, Department of Clinical Hematology Montpellier France

4. Medizinische Klinik und Poliklinik VUniversitätsklinikum Heidelberg Heidelberg Germany

5. Nationales Centrum für Tumorerkrankungen Heidelberg Germany

6. University of Montpellier, UFR de Médecine Montpellier France

7. UMR CNRS 5235University of Montpellier Montpellier France

Funder

Institut National Du Cancer

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.21730

Reference29 articles.

1. Multiple myeloma

2. Treatment of multiple myeloma

3. Better therapy requires better response evaluation: Paving the way for minimal residual disease testing for every myeloma patient

4. Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders

5. Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FCGR3A F158V alleles frequency differs in multiple myeloma patients from healthy population;OncoImmunology;2024-08-18

2. The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance;Frontiers in Immunology;2022-12-09

3. Comprehensive characterization of the epigenetic landscape in Multiple Myeloma;Theranostics;2022

4. RNA-Sequencing-Based Transcriptomic Score with Prognostic and Theranostic Values in Multiple Myeloma;Journal of Personalized Medicine;2021-09-30

5. RNA-sequencing data-driven dissection of human plasma cell differentiation reveals new potential transcription regulators;Leukemia;2021-04-06